Central Peninsula General Hospital INC.

Central Peninsula General Hospital INC. was paid $58.44M by Medicaid between Jan 2018 and Dec 2024, across 279 billing codes. Its largest line is 99285, emergency room visit (most serious) — 18% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	89,981	$7.53M
2019	88,440	$7.41M
2020	76,573	$6.69M
2021	87,885	$7.66M
2022	98,962	$9.34M
2023	102,366	$10.41M
2024incomplete	91,856	$9.40M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	18%	22,731	21,024	$10.62M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	14%	28,321	26,276	$8.40M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.1%	20,957	19,411	$4.71M
74177	Computed tomography, abdomen and pelvis; with contrast material	6.6%	3,522	3,344	$3.88M
H0047	Alcohol and/or other drug abuse services, not otherwise specified	4.0%	9,370	605	$2.34M
G0378	Hospital observation service, per hour	3.5%	2,545	1,767	$2.06M
70450	Computed tomography, head or brain; without contrast material	2.8%	2,671	2,528	$1.62M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.2%	15,049	4,797	$1.30M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.9%	11,292	9,883	$1.12M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.8%	1,065	1,013	$1.05M
71046	Radiologic examination, chest; 2 views	1.6%	5,648	5,312	$921K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.4%	2,142	2,095	$834K

267 more codes

90837	Psychotherapy session, about an hour	1.2%	6,603	$715K
71275	Computed tomographic angiography, chest, with contrast material	1.2%	629	$698K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.2%	745	$695K
90853	Group psychotherapy (other than of a multiple-family group)	1.2%	10,788	$683K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.1%	4,541	$654K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.0%	4,608	$590K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	866	$514K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	8,487	$508K
71045	Radiologic examination, chest; single view	<1%	4,668	$489K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	3,657	$483K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	7,145	$482K
96361	Intravenous infusion, hydration; each additional hour	<1%	6,110	$449K
H0015	Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education	<1%	8,370	$397K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	7,670	$357K
97602		<1%	6,331	$337K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,272	$333K
96375	Therapeutic injection; each additional sequential IV push	<1%	7,917	$327K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	2,890	$314K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	1,663	$299K
73562		<1%	1,636	$299K
73030		<1%	1,703	$276K
73630		<1%	1,480	$268K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	644	$262K
80053	Comprehensive metabolic panel	<1%	31,623	$260K
72100		<1%	1,730	$248K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,696	$246K
73610		<1%	1,191	$230K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	1,713	$218K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	35,557	$216K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,620	$214K
H2015	Community support for mental illness or disability, per 15 minutes	<1%	4,431	$209K
41899	Unlisted procedure, dentoalveolar structures	<1%	63	$206K
72125	Computed tomography, cervical spine; without contrast material	<1%	333	$187K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,284	$186K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	1,519	$179K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	252	$176K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	240	$176K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	228	$170K
S9484	Crisis intervention mental health services, per hour	<1%	1,472	$159K
73130		<1%	804	$157K
H0007	Alcohol and/or drug services; crisis intervention (outpatient)	<1%	3,099	$156K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	4,622	$155K
11721		<1%	4,085	$148K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	3,443	$145K
99214	Doctor's office visit, returning patient (more involved)	<1%	1,364	$143K
76830	Ultrasound, transvaginal	<1%	1,193	$142K
71250		<1%	331	$137K
84443	Thyroid stimulating hormone (TSH)	<1%	9,494	$135K
93971		<1%	450	$129K
73110		<1%	784	$124K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	1,040	$121K
97161		<1%	1,335	$121K
H0031	Mental health assessment, by non-physician	<1%	278	$117K
96376		<1%	2,780	$113K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	8,037	$112K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	2,205	$108K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,455	$98K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	454	$95K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,121	$94K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,517	$89K
73502		<1%	650	$84K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,189	$83K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,448	$82K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,446	$82K
80074		<1%	1,847	$80K
87507		<1%	179	$75K
90832	Psychotherapy session, about 30 minutes	<1%	1,365	$73K
72110		<1%	448	$72K
J7030	Infusion, normal saline solution , 1000 cc	<1%	7,591	$71K
J7050	Infusion, normal saline solution, 250 cc	<1%	8,344	$70K
99215	Doctor's office visit, returning patient (complex)	<1%	358	$67K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,794	$65K
84484		<1%	8,635	$62K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	73	$60K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	811	$59K
72040		<1%	332	$58K
76536		<1%	287	$55K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	522	$46K
87631		<1%	344	$45K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	697	$44K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	16	$43K
80061	Lipid panel	<1%	3,662	$43K
80306		<1%	2,938	$42K
76642		<1%	296	$41K
99213	Doctor's office visit, returning patient (routine)	<1%	683	$41K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	8,142	$39K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	7,122	$39K
97162		<1%	468	$38K
76770		<1%	250	$38K
83880		<1%	1,887	$37K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	43	$36K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	57	$35K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,158	$34K
83690		<1%	6,211	$33K
87806		<1%	1,182	$33K
87522	Neg quan hep c or qual rna	<1%	807	$32K
80048	Basic metabolic panel (calcium, ionized)	<1%	5,046	$32K
J2704	Injection, propofol, 10 mg	<1%	6,313	$31K
86140		<1%	7,268	$30K
87086	Culture, bacterial; quantitative colony count, urine	<1%	4,414	$30K
99152		<1%	268	$28K
81001		<1%	10,387	$27K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	1,126	$26K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	716	$26K
82077		<1%	1,954	$25K
86780		<1%	2,089	$25K
82728		<1%	2,081	$24K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	487	$23K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	4,501	$23K
82607		<1%	1,806	$23K
93017		<1%	107	$22K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,844	$22K
87486		<1%	645	$22K
87581		<1%	646	$22K
84439		<1%	2,788	$22K
82803		<1%	1,402	$21K
83605		<1%	2,807	$21K
90834	Psychotherapy session, about 45 minutes	<1%	237	$21K
87077		<1%	2,475	$19K
88312		<1%	178	$19K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	49	$18K
84703		<1%	2,482	$18K
H0046	Mental health services, not otherwise specified	<1%	467	$18K
93880		<1%	62	$17K
83735		<1%	3,967	$17K
87186		<1%	2,203	$17K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	9,157	$17K
96367		<1%	274	$16K
81025		<1%	2,056	$16K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	4,424	$16K
84702		<1%	1,034	$15K
86850		<1%	2,065	$15K
J1170	Injection, hydromorphone, up to 4 mg	<1%	2,686	$15K
72050		<1%	74	$14K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	12	$14K
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,997	$14K
87081		<1%	2,041	$13K
87040		<1%	1,762	$13K
80143		<1%	780	$12K
12001		<1%	80	$12K
74018		<1%	88	$12K
85379		<1%	1,556	$12K
80179		<1%	720	$11K
73140		<1%	71	$11K
90715		<1%	458	$10K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	2,094	$10K
86803		<1%	731	$9K
83540		<1%	1,673	$9K
85610		<1%	2,792	$9K
36591		<1%	201	$9K
36415	Collection of venous blood by venipuncture	<1%	22,330	$8K
94726		<1%	41	$8K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	27	$8K
85027		<1%	1,528	$8K
82746		<1%	613	$8K
J3490	Unclassified drugs	<1%	171	$7K
87070		<1%	852	$7K
J2060	Injection, lorazepam, 2 mg	<1%	1,192	$7K
73590		<1%	31	$7K
84403		<1%	295	$6K
H0001	Alcohol and/or drug assessment	<1%	27	$6K
85652		<1%	2,695	$6K
94060		<1%	28	$6K
82948		<1%	2,065	$6K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	365	$6K
83550		<1%	814	$6K
88307		<1%	48	$6K
C1769	Guide wire	<1%	13	$6K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,269	$5K
82947		<1%	2,210	$5K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	60	$5K
86901		<1%	2,129	$5K
86900		<1%	2,132	$5K
87510		<1%	301	$5K
87660		<1%	299	$5K
86038		<1%	465	$5K
87480		<1%	287	$5K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	473	$5K
84145		<1%	302	$5K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	304	$4K
94729		<1%	51	$4K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,058	$4K
T1023	Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter	<1%	114	$4K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	47	$4K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	520	$4K
99203	Doctor's office visit, new patient (routine)	<1%	81	$4K
87340		<1%	476	$4K
81003		<1%	2,205	$4K
J1790	Injection, droperidol, up to 5 mg	<1%	674	$4K
93970		<1%	13	$4K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	743	$4K
87205		<1%	878	$3K
86703		<1%	230	$3K
76775		<1%	24	$3K
97597		<1%	38	$3K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	681	$3K
84100		<1%	891	$3K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	36	$3K
82570		<1%	629	$3K
77002		<1%	38	$3K
Q9969	Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose	<1%	572	$3K
00811		<1%	12	$3K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	16	$2K
88142		<1%	141	$2K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	20	$2K
86200		<1%	173	$2K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	308	$2K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	37	$2K
84481		<1%	97	$2K
96415		<1%	33	$2K
82550		<1%	280	$2K
82533		<1%	125	$1K
97116		<1%	26	$1K
73560		<1%	15	$1K
84153		<1%	97	$1K
88342		<1%	27	$1K
T1016	Case management, each 15 minutes	<1%	20	$1K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	332	$1K
85730		<1%	280	$1K
83615		<1%	217	$1K
77066	Tomosynthesis, mammo	<1%	12	$1K
84466		<1%	92	$974.76
J2550	Injection, promethazine hcl, up to 50 mg	<1%	195	$961.02
94760		<1%	40	$917.79
88304		<1%	38	$860.62
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	165	$822.23
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	501	$818.25
83970		<1%	14	$758.72
C9113	Injection, pantoprazole sodium, per vial	<1%	144	$755.12
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	2,346	$720.87
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	94	$675.86
83090		<1%	38	$674.36
J0780	Injection, prochlorperazine, up to 10 mg	<1%	52	$570.59
J3411	Injection, thiamine hcl, 100 mg	<1%	94	$555.07
82565		<1%	167	$471.59
82784		<1%	29	$409.58
84550		<1%	106	$386.55
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	20	$366.74
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	72	$338.30
86762		<1%	26	$338.16
82670		<1%	13	$321.28
82043		<1%	71	$309.76
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	45	$269.32
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	39	$252.73
82378		<1%	15	$235.08
J1630	Injection, haloperidol, up to 5 mg	<1%	45	$225.84
83921		<1%	12	$222.71
84156		<1%	70	$189.65
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	13	$158.70
86431		<1%	27	$129.64
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	215	$128.86
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	12	$107.90
J1171	Injection, hydromorphone, 0.1 mg	<1%	26	$107.32
J2469	Injection, palonosetron hcl, 25 mcg	<1%	17	$103.74
86706		<1%	13	$102.00
85018		<1%	43	$95.15
87210		<1%	14	$80.90
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	15	$70.52
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	602	$27.84
J8540	Dexamethasone, oral, 0.25 mg	<1%	15	$16.72
0353U		<1%	740	$12.92
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	6,156	$6.16
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	154	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	79	$0.00
A9270	Non-covered item or service	0%	13,089	$0.00
0352U		0%	140	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDAVIS, RICK (CEO)